Navigation Links
diaDexus, Inc. Reports 2012 First Quarter Financial Results
Date:5/8/2012

INC.CONDENSED BALANCE SHEETS(In thousands)March 31,2012December 31,2011(unaudited)AssetsCurrent assets:Cash and cash equivalents$

12,203$

10,484Short-term investment securities3,7166,492Accounts receivable 2,3412,408Inventories163117Restricted cash400400Assets held for sale304304Prepaid expenses and other current assets799975Total current assets19,92621,180Long-term investments—250Restricted cash1,4001,400Property and equipment, net1,4851,350Other long-term assets150175Total assets$

22,961$

24,355Liabilities and Stockholders' Equity Current liabilities:Accounts payable$

1,281$

882Notes payable, current portion790372Deferred revenues, current portion342331Unfavorable lease obligations515492Accrued and other current liabilities2,0532,469Total current liabilities4,9814,546Non-current portion of notes payable4,1194,526Non-current portion of deferred revenue454530Non-current portion of deferred rent290266Non-current portion of unfavorable lease obligation2,9213,063Other long term liabilities301284Total liabilities13,06613,215Stockholders' equity:Preferred stock——Common stock531531Additional paid-in capital205,634205,557Accumulated other comprehensive loss(1)(5)Accumulated deficit (196,269)(194,943)Total stockholders' equity 9,89511,140Total liabilities and stockholders' equity$

22,961$

24,355
'/>"/>

SOURCE diaDexus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. diaDexus, Inc. Adds Two New Directors; Corporate Overview & 3Q Results Webcast Set for November 16, 2010
2. diaDexus, Inc. Reports 2010 Third Quarter Financial Results
3. diaDexus, Inc. Reports 2011 First Quarter Financial Results
4. diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter
5. diaDexus, Inc. to Host Webcast March 15, 2012 on 2011 Fourth Quarter and Year-End Financial Results
6. diaDexus, Inc. Reports 2011 Fourth Quarter and Year-End Financial Results
7. diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... today that VPII Escrow Corp., a newly formed wholly ... offer of approximately $3.2 billion aggregate principal amount of ... due in 2021 and in 2023, with final tranching ... use the net proceeds from the offering, together with ...
(Date:6/18/2013)... , June 18, 2013 Valeant Pharmaceuticals International, ... has priced its previously announced public offering of common ... will issue 23,529,412 common shares at a price of ... $2.0 billion. The Company will file a final prospectus ... S-3 and will make a similar filing with the ...
(Date:6/18/2013)...  Actavis, Inc. (NYSE: ACT ) today announced ... Securities and Exchange Commission (SEC) a registration statement on Form ... Chilcott plc (NASDAQ: WCRX ), which included ... (the "Form S-4"). As previously announced on ... entered into a definitive agreement pursuant to which Actavis will ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7
(Date:6/19/2013)... Pharmaceutical history is replete with ... with little or no understanding why they work, ... involved emerging years later. When Edward Tobinick ... rapid recovery of cognitive functions after perispinally administering ... known about the role inflammatory processes play in ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Middle ... throughout 2013 across all industries as cash rich buyers ... the differences across industries, all M&A transactions have a ... due diligence to verify the history and quality of ... considered. , But when due diligence involves a ...
(Date:6/19/2013)... Over the past five years, revenue ... has been growing at an annualized rate of 9.5% ... have supported the development of the industry including: substantial ... relatively higher drug prices in hospitals; and people's increased ... the development of chain drug retailing enterprises has also ...
(Date:6/18/2013)... Angeles, CA (PRWEB) June 19, 2013 ... of bariatric surgery, are holding complimentary weight loss seminars ... the detailed program can be accessed at their official ... minimizes surgery and recovery time. Their highly skilled panel ... to bariatric surgery. , A senior executive working ...
(Date:6/18/2013)... 18, 2013 Exposed Skin Care has finally ... acne suffers of all ages finally achieve the clear, beautiful ... products, this new acne clearing system combines the power of ... new acne from forming. , After a quick ... products are some of the most effective available on the ...
Breaking Medicine News(10 mins):Health News:Perispinally Administered Enbrel Facilitates Rapid Recovery of Cognitive Function in Patients with Alzheimer's 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 3Health News:Pharmacies and Drug Retailers in China Industry Research Report – Now Available from IBISWorld 2Health News:Pharmacies and Drug Retailers in China Industry Research Report – Now Available from IBISWorld 3Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3
... VANCOUVER, APRIL 1, 2009 New research funded by ... and learning difficulties for some childhood cancer survivors, especially ... in the journal Cancer , raises critical questions ... , "These are very significant findings," says Barbara Kaminsky, ...
... nurses, doctors and other front line cancer-care providers significantly ... with other healthcare workers, and with their own family, ... and Regenstrief Institute researchers published in the March issue ... , "The healthcare field is becoming more aware of ...
... new study, a therapeutic agent called sorafenib dramatically improved the ... approved in several countries for treatment of kidney and liver ... patients suffering from advanced portal hypertension, the authors suggest. Their ... a journal published by John Wiley & Sons on behalf ...
... out to adopt a child, the world pays attention. ... Malawi -- a small impoverished African nation. In ... to over a million, help is needed in many forms. ... with a mother and siblings, and the essentials of childhood ...
... physician groups clearly understand how to effectively analyze ... to be more innovative and establish more effective ... consultants The Practice Pros and Mediplay, Inc. have ... with assessing their marketing effectiveness. To take ...
... marketer of PurinaCare (R) Pet Health Insurance ( ... ( www.kgbtexas.com ) as its PR agency of ... June 2008, and is currently authorized to market pet health ... will help create and implement a strategic public relations and ...
Cached Medicine News:Health News:New research shows lower educational outcomes for survivors of childhood cancer 2Health News:Compassion fatigue: Impact on healthcare providers of caring for the terminally ill 2Health News:Compassion fatigue: Impact on healthcare providers of caring for the terminally ill 3Health News:Medication may improve portal hypertension 2Health News:In Malawi, Adoption is Not Enough 2Health News:Hey Doc, What's Your Marketing Strategy? 2Health News:Hey Doc, What's Your Marketing Strategy? 3Health News:KGBTexas Named Public Relations Agency of Record for PurinaCare(R) Pet Health Insurance 2Health News:KGBTexas Named Public Relations Agency of Record for PurinaCare(R) Pet Health Insurance 3
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... 4F, 5F, and 6F ... is ideal for coronary ... state-of-the-art technology and proprietary ... better responsiveness, optimal torque, ...
Medicine Products: